Back
HFA Premium Access

Therapeutic potential of phosphodiesterase 5 inhibitors in patients with heart failure with preserved ejection fraction (HFpEF) and combined post- and pre-capillary pulmonary hypertension (Cpc-PH).

Session: Moderated Poster session 6 - Therapy
Topic: Pulmonary hypertension
Speaker: Doctor T. Kramer (Cologne, DE)
Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Congress Presentation

Add to my library

Like

About the speaker

Doctor Tilmann Kramer

Cologne University Hospital - Heart Center, Cologne (Germany)
0 follower

9 more presentations in this session

Granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the RIGENERA trial): 10 years follow-up- FINAL RESULTS

Speaker: Doctor D. D'Amario (Novara, IT)

Access
Abstract
Like
Thumbnail

Feasibility and benefit of neurohumoral blocker uptitration following cardiac resynchronization therapy

Speaker: Doctor P. Martens (Genk, BE)

Access
Abstract
Slides
Like
Thumbnail

Relation of biological and functional LV remodeling to obstruction in hypertrophic cardiomyopathy. A rest and exercise echocardiographic study with longitudinal strain measurement

Speaker: Professor J. Trochu (Nantes, FR)

Access
Abstract
Like
Thumbnail

Early phase 99Tc-HMDP scintigraphy: a rapid and reliable technique for the diagnosis and typing of cardiac amyloidosis

Speaker: Professor T. Damy (Creteil, FR)

Access
Abstract
Like
Thumbnail

Less invasive ventricular reshaping provides sustained reduction of heart failure symptoms

Speaker: Doctor M. Biffi (Bologna, IT)

Access
Abstract
Like
Thumbnail

Access the full session

Moderated Poster session 6 - Therapy

Speakers: Doctor T. Kramer, Doctor D. D'Amario, Doctor P. Martens, Professor J. Trochu, Professor T. Damy...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources